250 related articles for article (PubMed ID: 6411170)
1. Failure of bromocriptine to maintain reduction in size of a macroprolactinoma.
Breidahl HD; Topliss DJ; Pike JW
Br Med J (Clin Res Ed); 1983 Aug; 287(6390):451-2. PubMed ID: 6411170
[TBL] [Abstract][Full Text] [Related]
2. Discordant responses of prolactinoma to two different dopamine agonists.
Ahmed SR; Shalet SM
Clin Endocrinol (Oxf); 1986 Apr; 24(4):421-6. PubMed ID: 3742834
[TBL] [Abstract][Full Text] [Related]
3. Bromocriptine reduction of prolactinoma size.
Corenblum B; Hanley DA
Fertil Steril; 1981 Dec; 36(6):716-9. PubMed ID: 7308514
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and drug therapy of prolactinoma.
Ciccarelli E; Camanni F
Drugs; 1996 Jun; 51(6):954-65. PubMed ID: 8736617
[TBL] [Abstract][Full Text] [Related]
5. Rapid size reduction of giant prolactinoma following medical treatment.
Perani D; Colombo N; Scotti G; Tonon C
J Comput Assist Tomogr; 1984 Feb; 8(1):131-3. PubMed ID: 6690496
[TBL] [Abstract][Full Text] [Related]
6. Dramatic and rapid shrinkage of a massive invasive prolactinoma with bromocriptine: a case report.
Clayton RN; Webb J; Heath DA; Dunn PJ; Rolfe EB; Hockley AD
Clin Endocrinol (Oxf); 1985 May; 22(5):573-81. PubMed ID: 4028456
[TBL] [Abstract][Full Text] [Related]
7. Reduction of pituitary-tumour size in patients with prolactinomas and acromegaly treated with bromocriptine with or without radiotherapy.
Wass JA; Moult PJ; Thorner MO; Dacie JE; Charlesworth M; Jones AE; Besser GM
Lancet; 1979 Jul; 2(8133):66-9. PubMed ID: 87966
[TBL] [Abstract][Full Text] [Related]
8. Transient intrasellar collection of air during bromocriptine treatment of a prolactinoma.
Fagel WJ; Hekster RE; Smith SJ; van der Vijver JC
Neuroradiology; 1986; 28(4):364-6. PubMed ID: 3762918
[TBL] [Abstract][Full Text] [Related]
9. Effect of dopamine agonist withdrawal after long-term therapy in prolactinomas. Studies with high-definition computerised tomography.
Johnston DG; Hall K; Kendall-Taylor P; Patrick D; Watson M; Cook DB
Lancet; 1984 Jul; 2(8396):187-92. PubMed ID: 6146751
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid rhinorrhea during treatment with bromocriptine for prolactinoma.
Kok JG; Bartelink AK; Schulte BP; Smals A; Pieters G; Meyer E; Merx H
Neurology; 1985 Aug; 35(8):1193-5. PubMed ID: 4022353
[TBL] [Abstract][Full Text] [Related]
11. Changes in computed tomographic findings in microprolactinomas before and after bromocriptine.
Demura R; Kubo O; Demura H; Shizume K; Kitamura K
Acta Endocrinol (Copenh); 1985 Nov; 110(3):308-12. PubMed ID: 4072572
[TBL] [Abstract][Full Text] [Related]
12. Effect of bromocriptine and pergolide on pituitary tumor size and serum prolactin.
Horowitz BL; Hamilton DJ; Sommers CJ; Bryan RN; Boyd AE
AJNR Am J Neuroradiol; 1983; 4(3):415-7. PubMed ID: 6410759
[TBL] [Abstract][Full Text] [Related]
13. Pregnancy after bromocriptine-induced reduction of an extrasellar prolactin-secreting pituitary macroadenoma.
Goodman LA; Chang RJ
Obstet Gynecol; 1984 Sep; 64(3 Suppl):2S-7S. PubMed ID: 6433250
[TBL] [Abstract][Full Text] [Related]
14. Effects of bromocriptine for prolactin-secreting adenomas: analysis by CT scan.
Niwa J; Sato O; Tanabe S
Comput Radiol; 1983; 7(4):237-41. PubMed ID: 6641185
[TBL] [Abstract][Full Text] [Related]
15. Large macroprolactinoma treated with bromocriptine alone.
Loh KC; Shlossberg AH
Ann Acad Med Singap; 1996 Nov; 25(6):886-9. PubMed ID: 9055023
[TBL] [Abstract][Full Text] [Related]
16. Cavernous sinus syndrome due to prolactinoma: resolution with bromocriptine.
King LW; Molitch ME; Gittinger JW; Wolpert SM; Stern J
Surg Neurol; 1983 Mar; 19(3):280-4. PubMed ID: 6836484
[TBL] [Abstract][Full Text] [Related]
17. Visual function in prolactinoma patients treated with bromocriptine.
Moster ML; Savino PJ; Schatz NJ; Snyder PJ; Sergott RC; Bosley TM
Ophthalmology; 1985 Oct; 92(10):1332-41. PubMed ID: 4069600
[TBL] [Abstract][Full Text] [Related]
18. The long-term effects of megavoltage radiotherapy as sole or combined therapy for large prolactinomas: studies with high definition computerized tomography.
Johnston DG; Hall K; Kendall-Taylor P; Ross WM; Crombie AL; Cook DB; Watson MJ
Clin Endocrinol (Oxf); 1986 Jun; 24(6):675-85. PubMed ID: 3098457
[TBL] [Abstract][Full Text] [Related]
19. Recurrent prolactinoma and meningioma following irradiation and bromocriptine treatment.
Kolodny J; Dluhy RG
Am J Med; 1985 Jan; 78(1):153-5. PubMed ID: 3966480
[TBL] [Abstract][Full Text] [Related]
20. Invasive mixed growth hormone/prolactin secreting pituitary tumour: complete shrinking by octreotide and bromocriptine, and lack of tumour growth relapse 20 months after octreotide withdrawal.
Sadoul JL; Thyss A; Freychet P
Acta Endocrinol (Copenh); 1992 Feb; 126(2):179-83. PubMed ID: 1543025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
